NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/19/2024
Back to search
Official data from USPTO
FRONTIER MEDICINES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FRONTIER MEDICINES
ST13
US500000090981166Class
5, 42
Filing
90981166
Registration
7572756
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
61
Latest update
11/19/2024
Trademark type
Word
Nice classes
5, 42
Filing date
08/13/2020
Registration date
11/19/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2024
Last transaction
11/19/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/20/2023
First use in commerce
11/20/2023
Drawing code
4
Owner type
03
Owner location
South San Francisco, CA, US
Examiner
SCLEIDOROVICH, JOANNA YAEL
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
F. C. (pessoa física)
Representatives
Muzamil Huq MORRISON & FOERSTER LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Small molecule pharmaceuticals for the treatment of cancer
Class 42
pharmaceutical research services; pharmaceutical products development; research and development of pharmaceuticals for the treatment of cancer
Publications
History of USPTO decisions and trademark events.
61 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/19/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/12/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/09/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
09/09/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/21/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
08/21/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/24/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
05/18/2024
IUAF
USE AMENDMENT FILED
05/17/2024
DRRR
DIVISIONAL REQUEST RECEIVED
05/17/2024
EISU
TEAS STATEMENT OF USE RECEIVED
05/17/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/17/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/16/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/16/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/16/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/06/2024
EX4G
SOU EXTENSION 4 GRANTED
04/05/2024
EXT4
SOU EXTENSION 4 FILED
04/05/2024
EEXT
SOU TEAS EXTENSION RECEIVED
04/05/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/28/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/28/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/28/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/28/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/12/2023
EX3G
SOU EXTENSION 3 GRANTED
09/08/2023
EXT3
SOU EXTENSION 3 FILED
09/08/2023
EEXT
SOU TEAS EXTENSION RECEIVED
09/08/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/04/2023
EX2G
SOU EXTENSION 2 GRANTED
03/31/2023
EXT2
SOU EXTENSION 2 FILED
03/31/2023
EEXT
SOU TEAS EXTENSION RECEIVED
03/31/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/29/2022
EX1G
SOU EXTENSION 1 GRANTED
09/27/2022
EXT1
SOU EXTENSION 1 FILED
09/27/2022
EEXT
SOU TEAS EXTENSION RECEIVED
09/27/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/08/2022
PUBO
PUBLISHED FOR OPPOSITION
02/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/19/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
12/15/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/15/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
12/15/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/15/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/06/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/04/2021
GNSL
LETTER OF SUSPENSION E-MAILED
06/04/2021
CNSL
SUSPENSION LETTER WRITTEN
06/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/27/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/27/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/27/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/15/2020
GNRT
NON-FINAL ACTION E-MAILED
12/15/2020
CNRT
NON-FINAL ACTION WRITTEN
12/15/2020
DOCK
ASSIGNED TO EXAMINER
12/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2020
NWAP
NEW APPLICATION ENTERED
08/17/2020
Continuous trademark protection
Get notified about every new filing that threatens FRONTIER MEDICINES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.